- Home
- NOTE vs MIRA Comparison
NOTE vs MIRA Comparison
Compare NOTE & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTE
- MIRA
- Stock Information
- Founded
- NOTE 2013
- MIRA 2020
- Country
- NOTE United States
- MIRA United States
- Employees
- NOTE N/A
- MIRA N/A
- Industry
- NOTE EDP Services
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- NOTE Technology
- MIRA Health Care
- Exchange
- NOTE Nasdaq
- MIRA Nasdaq
- Market Cap
- NOTE 39.9M
- MIRA 33.7M
- IPO Year
- NOTE N/A
- MIRA 2023
- Fundamental
- Price
- NOTE $2.14
- MIRA $1.45
- Analyst Decision
- NOTE Strong Buy
- MIRA
- Analyst Count
- NOTE 4
- MIRA 0
- Target Price
- NOTE $29.25
- MIRA N/A
- AVG Volume (30 Days)
- NOTE 251.5K
- MIRA 514.1K
- Earning Date
- NOTE 11-06-2025
- MIRA 11-13-2025
- Dividend Yield
- NOTE N/A
- MIRA N/A
- EPS Growth
- NOTE N/A
- MIRA N/A
- EPS
- NOTE N/A
- MIRA N/A
- Revenue
- NOTE $102,673,000.00
- MIRA N/A
- Revenue This Year
- NOTE N/A
- MIRA N/A
- Revenue Next Year
- NOTE $4.61
- MIRA N/A
- P/E Ratio
- NOTE N/A
- MIRA $1.90
- Revenue Growth
- NOTE N/A
- MIRA N/A
- 52 Week Low
- NOTE $2.05
- MIRA $0.73
- 52 Week High
- NOTE $24.36
- MIRA $2.45
- Technical
- Relative Strength Index (RSI)
- NOTE 18.97
- MIRA 46.36
- Support Level
- NOTE $2.50
- MIRA $1.27
- Resistance Level
- NOTE $3.28
- MIRA $1.45
- Average True Range (ATR)
- NOTE 0.33
- MIRA 0.10
- MACD
- NOTE -0.14
- MIRA -0.03
- Stochastic Oscillator
- NOTE 7.94
- MIRA 29.17
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.